4D Molecular Therapeutics Funding & Investors
Emeryville, CA
4d Molecular Therapeutics, LLC operates as a biotechnology company. The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions. 4d Molecular Therapeutics serves customers in the State of California.
4dmoleculartherapeutics.comTotal Amount Raised: $595,000,000
4D Molecular Therapeutics Funding Rounds
Post Ipo Equity
$300,000,000
Post Ipo Equity
$120,000,000
Series C
$75,000,000
Series C Investors
Viking Global InvestorsCystic Fibrosis FoundationRidgeback Capital ManagementAmzak Health InvestorsArrowMark Colorado HoldingsCasdin CapitalPerceptive AdvisorsBerkeley Catalyst FundPfizer Venture InvestmentsQUAD Investment ManagementChiesi VenturesPappas CapitalBVF PartnersMirae Asset Financial GroupLongevity Vision FundOctagon Capital AdvisorsIPO
Unknown
Series B
$90,000,000
Series B Investors
Viking Global InvestorsCureDuchenne VenturesRidgeback Capital ManagementMirae AssetPerceptive AdvisorsArrowMark Colorado HoldingsJanus Henderson InvestorsPappas CapitalPfizer Venture InvestmentsBerkeley Catalyst FundChiesi VenturesBVF PartnersSeries Unknown
$3,000,000
Series Unknown Investors
Cystic Fibrosis FoundationSeries Unknown
$6,999,995
Funding info provided by Diffbot.